MCID: URT014
MIFTS: 44

Ureterolithiasis

Categories: Nephrological diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Ureterolithiasis

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis 11 43 14 16 71 75 33
Calculus of Ureter 11 31 33
Ureteral Calculi 71 33
Ureteric Stone 11 33
Ureteral Calculus or Stone 33
Ureterolithiasis Nos 33
Stone in the Ureter 33
Ureteric Calculus 11
Ureter Calculi 33
Ureterolith 33

Classifications:



External Ids:

Disease Ontology 11 DOID:14146
ICD9CM 34 592.1
MeSH 43 D053039
NCIt 49 C114696
SNOMED-CT 68 31054009
ICD10 31 N20.1
ICD11 33 1920593940
UMLS 71 C0041952 C1456865

Summaries for Ureterolithiasis

Disease Ontology: 11 An ureteral disease this is characterized by the formation of stoney concentrations in the ureter.

MalaCards based summary: Ureterolithiasis, also known as calculus of ureter, is related to nephrolithiasis and hydronephrosis. An important gene associated with Ureterolithiasis is ADRA1A (Adrenoceptor Alpha 1A), and among its related pathways/superpathways are 4-hydroxyproline degradation and Sympathetic Nerve Pathway (Neuroeffector Junction). The drugs Sodium citrate and Sildenafil have been mentioned in the context of this disorder. Affiliated tissues include kidney, spinal cord and adrenal gland.

Wikipedia: 75 Kidney stone disease, also known as nephrolithiasis or urolithiasis, is a crystallopathy where a solid... more...

Related Diseases for Ureterolithiasis

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 406)
# Related Disease Score Top Affiliating Genes
1 nephrolithiasis 30.4 PTH GRHPR F2 AGXT
2 hydronephrosis 30.3 KLK3 CRP ALB
3 prostatic hyperplasia, benign 30.3 PDE5A KLK3 ADRA1A
4 urolithiasis 30.2 F2 ALB AGXT
5 urethral calculus 30.1 KLK3 GRHPR
6 adenine phosphoribosyltransferase deficiency 30.0 GRHPR AGXT
7 urinary tract obstruction 29.9 KLK3 CRP ALB
8 peritonitis 29.8 F2 CRP ALB
9 acute pyelonephritis 29.8 CRP ALB
10 chronic pyelonephritis 29.8 PTH CRP ALB
11 cystic kidney disease 29.8 PTH CRP ALB
12 renal tuberculosis 29.7 CRP ALB AGXT
13 hyperphosphatemia 29.7 PTH CRP ALB
14 uremia 29.7 PTH CRP ALB
15 hyperuricemia 29.7 PTH CRP ALB
16 anuria 29.7 F2 CRP ALB
17 nephrocalcinosis 29.7 GRHPR ALB AGXT
18 hypertensive encephalopathy 29.7 F2 CRP ALB
19 chronic kidney disease 29.7 PTH CRP ALB AGXT
20 urethral stricture 29.7 PDE5A KLK3 CRP ADRA1D
21 urogenital tuberculosis 29.6 KLK3 CRP ALB
22 paralytic ileus 29.6 F2 CRP ALB
23 urinary tract infection 29.6 KLK3 F2 CRP ALB
24 pyuria 29.4 KLK3 F2 CRP ALB
25 schistosomiasis 29.4 F2 CRP ALB
26 neurogenic bladder 29.4 PDE5A KLK3 CRP ALB
27 kidney disease 29.1 PTH F2 CRP ALB AGXT
28 prostatic hypertrophy 29.0 PDE5A KLK3 CRP ALB ADRA1D ADRA1A
29 nephrolithiasis, calcium oxalate 10.6
30 ureteral obstruction 10.4
31 pulmonary valve insufficiency 10.3 PDE5A CRP
32 dental abscess 10.3 PTH CRP
33 pyelonephritis 10.3
34 appendicitis 10.3
35 enthesopathy 10.2 PTH CRP
36 diastolic heart failure 10.2 PDE5A CRP
37 diffuse idiopathic skeletal hyperostosis 10.2 PTH CRP
38 toxic shock syndrome 10.2
39 ileus 10.2
40 bursitis 10.2 PTH CRP
41 japanese spotted fever 10.2 IRGC CRP
42 orbital osteomyelitis 10.2 F2 CRP
43 achenbach syndrome 10.2 F2 CRP
44 bladder neck obstruction 10.2 PDE5A KLK3
45 synovial angioma 10.2 F2 CRP
46 emphysematous cholecystitis 10.2 F2 CRP
47 femoral neuropathy 10.2 F2 CRP
48 blue toe syndrome 10.2 F2 CRP
49 renal pelvis squamous cell carcinoma 10.2 F2 CRP
50 subclavian steal syndrome 10.2 F2 CRP

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)


Acute Cystitis Bladder Neck Obstruction
Hydronephrosis Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure Paralytic Ileus
Prostate Cancer Prostatic Hypertrophy
Pyelonephritis Urethral Calculus
Urethral Stricture Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:



Diseases related to Ureterolithiasis

Symptoms & Phenotypes for Ureterolithiasis

Drugs & Therapeutics for Ureterolithiasis

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 76)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sodium citrate Approved, Investigational Phase 4 68-04-2 23431961
2
Sildenafil Approved, Investigational Phase 4 139755-83-2, 171599-83-0 5212 135398744
3
Nefopam Approved, Investigational Phase 4 13669-70-0 4450
4
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
5
Morphine Approved, Investigational Phase 4 57-27-2 5288826
6
Parecoxib Approved Phase 4 198470-84-7 119828
7
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
8
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
9
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1, 93107-08-5 2764
10
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
11
Tamsulosin Approved, Investigational Phase 4 106133-20-4 129211
12
Silodosin Approved Phase 4 160970-54-7 9891967 5312125
13
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
14
Naftopidil Investigational Phase 4 57149-07-2 4418
15 Neurotransmitter Agents Phase 4
16 Adrenergic Antagonists Phase 4
17 Adrenergic alpha-Antagonists Phase 4
18 Adrenergic Agents Phase 4
19 Hormones Phase 4
20 Antihypertensive Agents Phase 4
21 Calcium, Dietary Phase 4
22 calcium channel blockers Phase 4
23 Platelet Aggregation Inhibitors Phase 4
24 Citrate Phase 4
25 Antipyretics Phase 4
26
Ketorolac Tromethamine Phase 4
27 Analgesics, Opioid Phase 4
28 Narcotics Phase 4
29 Antibiotics, Antitubercular Phase 4
30 Anti-Bacterial Agents Phase 4
31 Anti-Infective Agents Phase 4
32 Cytochrome P-450 Enzyme Inhibitors Phase 4
33 Vasodilator Agents Phase 4
34 Phosphodiesterase Inhibitors Phase 4
35 Phosphodiesterase 5 Inhibitors Phase 4
36
Calcium Nutraceutical Phase 4 7440-70-2 271
37
Doxazosin Approved Phase 3 74191-85-8 3157
38
Nifedipine Approved Phase 3 21829-25-4 4485
39
Prazosin Approved Phase 3 19216-56-9 4893
40
Aceclofenac Approved, Investigational Phase 3 89796-99-6 71771
41
Tramadol Approved, Investigational Phase 3 27203-92-5 33741 5523
42
Furosemide Approved, Vet_approved Phase 3 54-31-9 3440
43
Midazolam Approved, Illicit Phase 3 59467-70-8 4192
44 Tocolytic Agents Phase 3
45 Sodium Potassium Chloride Symporter Inhibitors Phase 3
46 diuretics Phase 3
47
Mirabegron Approved Phase 2 223673-61-8 18319735 9865528
48 Adrenergic beta-Agonists Phase 2
49 Adrenergic beta-3 Receptor Agonists Phase 2
50 Adrenergic Agonists Phase 2

Interventional clinical trials:

(show top 50) (show all 88)
# Name Status NCT ID Phase Drugs
1 The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study Unknown status NCT00489112 Phase 4 Alfuzocine XL 10 mg once a day
2 Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone Unknown status NCT02519153 Phase 4 Sildenafil
3 A Comparison Between Flexible Ureteroscopy, Semirigid Ureteroscopy and Extracorporeal Shockwaves Lithotripsy (SWL) in The Management of Proximal Ureteric Stones. A Randomized Controlled Trial Unknown status NCT02469766 Phase 4
4 Efficacy of Tamsulosin OCAS in the Conjunctive Medical Treatment of Distal Ureteral Stones.A Randomized, Double-blind, Placebo-controlled Study Unknown status NCT01167062 Phase 4 Tamsulosin Hydrochloride OCAS 0.4 mg
5 The Effectiveness and Safety of Naftopidil 75mg for Improving Clearance of Ureteral and Renal Stones After Shockwave Lithotripsy: Prospective Randomized Controlled Study Unknown status NCT02011737 Phase 4 naftopidil 75mg
6 Interest of Néfopam in the Treatment of Pain During the Intense Ureteral Calculi Uncomplicated in Adults in Emergencies Unit. Completed NCT00639574 Phase 4 Néfopam
7 Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Due to Ureteric Calculi: Randomized Controlled Trial Completed NCT03704623 Phase 4 Paracetamol;Parecoxib
8 Study of Tamsulosin for Urolithiasis in the Emergency Department Completed NCT00382265 Phase 4 tamsulosin
9 Study of Ketorolac Versus Opioid for Pain After Endoscopy (SKOPE): A Double-blinded Randomized Control Trial Comparing Outpatient Analgesic Efficacy of NSAIDs and Opioids in Patients Undergoing Ureteroscopy for Kidney Stones Completed NCT03888144 Phase 4 Oxycodone;Ketorolac
10 A 4-week, Double-blind, Randomized, Comparative and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones. Completed NCT01533389 Phase 4 Silodosin;Placebo
11 A Multicenter Randomized Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on Reducing Urinary Tract Infection Recruiting NCT03692715 Phase 4 Ciprofloxacin;Placebo
12 Comparative Study Between Tadalafil Versus Tamsulosin as a Medical Expulsive Therapy for Lower Ureteric Stones Active, not recruiting NCT04641507 Phase 4 Tadalafil versus tamsulosin as MET
13 Efectividad de la Tamsulosina Como Tratamiento Adyuvante Previo a Ureterolitotomia Endoscopica Terminated NCT03614052 Phase 4 Tamsulosin Hydrochloride 0.4 milligrams;Placebo Oral Tablet
14 Comparison of Silodosin vs. Tamsulosin on Spontaneous Passage of Acutely Obstructing Ureteral Calculi in Medical Expulsive Therapy Terminated NCT02369744 Phase 4 Silodosin;Tamsulosin
15 Celecoxib in the Management of Acute Renal Colic Withdrawn NCT00304317 Phase 4 celecoxib
16 Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones Unknown status NCT00713739 Phase 3 Alfuzosin;nifedipine;doxazosin;prazosin
17 Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones Completed NCT00151567 Phase 3 Tamsulosin;Placebo
18 Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study Completed NCT01952314 Phase 3 Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
19 Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones Completed NCT04557202 Phase 3 Tamsulosin Oral Capsule;Placebo
20 Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Completed NCT00177086 Phase 3
21 Effect of Furosemide on Outcome of Extracorporeal Shock Wave Lithotripsy for Renal and Ureteral Calculi; a Randomized, Triple-blinded, Controlled Trial Recruiting NCT05270421 Phase 3 Furosemide 40 mg
22 Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin Unknown status NCT00478998 Phase 2 Tamsulosin
23 Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL. Unknown status NCT00409227 Phase 2 Alpha blocker-alfuzosin;placebo
24 A Double Blind Placebo Control Trial of Mirabegron for Medical Expulsive Therapy and to Manage Stent Pain for Ureteral Stones(Protocol # 01-16-20-02) Completed NCT02744430 Phase 2 Mirabegron
25 Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Completed NCT04695951 Phase 2
26 A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage Completed NCT01144949 Phase 2 silodosin;placebo
27 URIPRENE: Feasibility Study to Evaluate the Preliminary Safety and Effectiveness of the Uriprene Stent Following Uncomplicated Ureteroscopy Completed NCT02032316 Phase 1
28 Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Unknown status NCT02279927
29 The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms: A Prospective Randomized Study Unknown status NCT03274700 Early Phase 1 Tamsulosin.;Placebo.
30 External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone: A Multi-center Prospective Randomized Controlled Trial Unknown status NCT03730389
31 Does Preoperative Tamsulosin Facilitate Semi-rigid Ureteroscopic Management of Lower Ureteric Calculi Prospective, Randomized Double Blind Study Unknown status NCT04602403
32 The Impact of Silent Ureteral Stone on Renal Function and Kidney Anatomy: a Prospective Analysis Unknown status NCT01884870
33 Randomized Controlled Trial Comparing Surgical Outcomes Following PCNL Under Ultrasound Control and PCNL Under Fluoroscopic Control in the Treatment of Kidney Stones Unknown status NCT04606758
34 Staged Ureteroscopy After Initial Urinary Drainage Versus Direct Ureteroscopy in the Treatment of Pediatric Obstructive Calcular Anuria Unknown status NCT02139059
35 Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone Unknown status NCT00397397
36 The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones. A Randomized Clinical Trial Unknown status NCT03243682
37 Shockwave Lithotripsy (SWL) Under Regular General Anesthesia and Under General Anesthesia Using Bronchial Blocker. Unknown status NCT01008267
38 Influence of Patient Decision-Making Aids for Patients With Unilateral Ureteral Stone: A Randomized-Controlled Trial Unknown status NCT04504084
39 Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial Unknown status NCT01450566 Lidocaine;Saline
40 Effectiveness of Drainage of the Kidney by Percutaneous Nephrostomy Catheter Placement Vs. Retrograde Double J Catheter Placement in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis Unknown status NCT04594161
41 Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis Completed NCT00762424 Flowmax;placebo
42 Ultrasound Non-contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up Completed NCT02539004
43 Ureteroscopic Lithotripsy in the Reverse Trendelenburg Position for Upper Ureteral Stones: a Prospective, Randomized, Comparative Study Completed NCT04894058
44 Medical Expulsive Therapy of Single Distal Ureteral Stones. A Randomised, Double-blind and Placebo-controlled Study Completed NCT00831701 Tamsulosin;Placebo
45 Comparison of Pro Seal and Baska-mask Completed NCT04186455
46 Comparison Between Symptomps Related to Pigtail Suture Stent Versus Conventional Double J After Ureterorenoscopy for Stone Treatment. A Prospective Randomized Trial Completed NCT03344120
47 Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone Completed NCT03726502
48 The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcome of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter Completed NCT00517205
49 The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients Completed NCT00448123 Tamsulosin;Placebo
50 Ultraslow Full-power SWL Versus Slow SWL in Stones With High Attenuation Value Completed NCT03795545

Search NIH Clinical Center for Ureterolithiasis

Cochrane evidence based reviews: ureterolithiasis

Genetic Tests for Ureterolithiasis

Anatomical Context for Ureterolithiasis

Organs/tissues related to Ureterolithiasis:

MalaCards : Kidney, Spinal Cord, Adrenal Gland, Smooth Muscle, Neutrophil, Prostate, Colon

Publications for Ureterolithiasis

Articles related to Ureterolithiasis:

(show top 50) (show all 2529)
# Title Authors PMID Year
1
Predictive factors for stone management timing after emergency percutaneous nephrostomy drainage in patients with infection and hydronephrosis secondary to ureteral calculi. 62
36454363 2022
2
Randomized comparison of 4.5/6 Fr versus 6/7.5 Fr ureteroscopes for laser lithotripsy of lower/middle ureteral calculi: towards optimization of efficacy and safety of semirigid ureteroscopy. 62
36208314 2022
3
Ureteral calculi lithotripsy for single ureteral calculi: can DNN-assisted model help preoperatively predict risk factors for sepsis? 62
35731290 2022
4
A systematic review and meta-analysis of clinical signs, symptoms, and imaging findings in patients with suspected renal colic. 62
36474707 2022
5
Acute extracorporeal shockwave lithotripsy for ureteric stones - 7-years' experience from a busy district general hospital. 62
35689415 2022
6
Upper ureteral calculi complicated with severe hydronephrosis and renal medullary carcinoma in elderly Chinese woman: A case report. 62
36450622 2022
7
A giant ureteric calculus successfully removed by mini-endoscopic combined intrarenal surgery: A case report. 62
36337173 2022
8
Obstructing Ureteral Calculi and Presumed Infection: Impact of Antimicrobial Duration and Time From Decompression to Stone Treatment in Developing Urosepsis. 62
36334770 2022
9
Ambulatory Minimally-invasive Endoscopic Combined Intra-Renal Surgery in management of Large Impacted Proximal Ureteral Calculi: A feasibility study at a tertiary referral centre. 62
36401507 2022
10
A pediatric case of ureterolithiasis due to cystinuria accompanied by acute appendicitis; a case report. 62
36115118 2022
11
Where are the paediatric patients with testicular torsion during the COVID-19 pandemic? 62
34664222 2022
12
Regeneration of the ureter using a scaffold-free live-cell structure created with the bio-three-dimensional printing technique. 62
36243376 2022
13
Impact of Stone Localization before Emergency Ureteral Stenting on Further Stone Treatment. 62
36282063 2022
14
Ureterolithiasis in unilateral duplex kidney with completely duplicated ureters. 62
35780030 2022
15
Factors Affecting the Outcome of Medical Treatment in Cats with Obstructive Ureteral Stones Treated with Tamsulosin: 70 Cases (2018-2022). 62
36288181 2022
16
Risk of future stroke in patients with a diagnosis of peripheral vertigo in the emergency department. 62
36056876 2022
17
Choosing the best way for urinary decompression and developing a novel predictive model for septic shock using SOFA in these patients. 62
36070249 2022
18
Community-onset urosepsis: incidence and risk factors for 30-day mortality - a retrospective cohort study. 62
36127849 2022
19
Management of encrusted ureteral stents: Two center experience. 62
36165475 2022
20
Efficacy of ultrasound monitoring during extracorporeal shock wave lithotripsy: A multi-institutional propensity score-matched study. 62
35871263 2022
21
Low-Dose CT for Renal Calculi Detection Using Spectral Shaping of High Tube Voltage. 62
35272363 2022
22
Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study. 62
36083711 2022
23
Transvesicoscopic ureteral reimplantation and ureteroscopy for management of primary obstructed non-refluxing megaureter with ureteral calculus. 62
36090926 2022
24
Reducing the rate of negative ureteroscopy: predictive factors and the role of preoperative imaging. 62
35133211 2022
25
Impact of forced diuresis on retropulsion of disintegrated ureteral calculi during semi-rigid ureteroscopy: a double-blind randomized-controlled study. 62
35451636 2022
26
Therapeutic Living Donor Nephrectomy for Proximal Ureteral Pathology: A Longitudinal Case Series. 62
35550384 2022
27
Symptomatic Hydronephrosis and Ureteral Calculi in Pregnancy: A Narrative Review with a Proposed Management Protocol. 62
35345895 2022
28
Potential Markers to Reduce Non-Contrast Computed Tomography Use for Symptomatic Patients with Suspected Ureterolithiasis. 62
36013299 2022
29
The role of a urine dipstick in the diagnosis of the acute scrotum. 62
35783592 2022
30
Open Ureteric Exploration in Aminu Kano Teaching Hospital: Indications and Outcome. 62
36388738 2022
31
The effect of perirenal fat stranding on infectious complications after ureterorenoscopy in patients with ureteral calculi. 62
36035336 2022
32
Construction of a novel rabbit model of ureteral calculi implanted with flowable resin. 62
35850713 2022
33
Massive Ureterolithiasis. 62
36039196 2022
34
A rare complication of percutaneous nephrolithotomy: Jejunal perforation and its management. 62
35300354 2022
35
Laparoscopic surgery for renal cyst and upper ureteral calculi in patients with duplex kidney: A case report. 62
35843816 2022
36
An unusual case of spontaneous rupture of the renal pelvis. 62
35368982 2022
37
Intravesical aminophylline instillation as an alternative for balloon dilatation prior to semi-rigid ureteroscopic management of distal ureteral stones. 62
35618855 2022
38
Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis. 62
35441879 2022
39
Clinical Low Dose Photon Counting CT for the Detection of Urolithiasis: Evaluation of Image Quality and Radiation Dose. 62
35894003 2022
40
Sheathed flexible retrograde intrarenal surgery without safety guide wire for upper urinary tract stones. 62
35775345 2022
41
Effect of targeting and generator type on efficacy of extracorporeal shock wave lithotripsy. 62
35801399 2022
42
A simple predictive model with internal validation for assessment of stone-left after ureteroscopic lithotripsy in upper ureteral stones. 62
35812191 2022
43
Successful Treatment of Ureteral Obstructive Lithiasis by Ureterotomy in a Domestic Hen. 62
35526167 2022
44
Obstructive struvite ureterolithiasis in 4-month-old intact male Bernese mountain dog. 62
35502263 2022
45
A multicenter, double-blind, placebo-controlled parallel study to evaluate the role of Yinhua Miyanling tablets in the prevention of bacterial biofilm formation on ureteral stents: a randomised trial. 62
35672892 2022
46
Retrograde intrarenal surgery for impacted upper ureteral stone in a patient with advanced lumbar scoliosis and lower-extremity development defect: a case report. 62
35614450 2022
47
The Efficacy of Sexual Intercourse Or Masturbation For The Expulsion Of Distal Ureteral Stones In Men: A Systematic Review And Meta-analysis Of Randomized-controlled Trials. 62
35598041 2022
48
The use of 14/16Fr ureter access sheath for safe and effective management of large upper ureteral calculi. 62
35150299 2022
49
Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria. 62
35170870 2022
50
Efficacy of supine trans-abdominal pronated shock head ESWL for treatment of distal ureteric stones: A pilot study. 62
35422154 2022

Variations for Ureterolithiasis

Expression for Ureterolithiasis

Search GEO for disease gene expression data for Ureterolithiasis.

Pathways for Ureterolithiasis

Pathways related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.35 GRHPR AGXT
2 9.98 ADRA1D ADRA1A

GO Terms for Ureterolithiasis

Biological processes related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuron-glial cell signaling GO:0150099 9.46 ADRA1D ADRA1A
2 adrenergic receptor signaling pathway GO:0071875 9.26 ADRA1D ADRA1A
3 glyoxylate metabolic process GO:0046487 9.26 GRHPR AGXT
4 positive regulation of heart rate by epinephrine-norepinephrine GO:0001996 8.92 ADRA1D ADRA1A

Molecular functions related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 adrenergic receptor activity GO:0004935 8.96 ADRA1D ADRA1A
2 alpha1-adrenergic receptor activity GO:0004937 8.92 ADRA1D ADRA1A

Sources for Ureterolithiasis

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....